Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Sephora and L’Oréal strong results suggest Ulta may have overstated beauty industry challenges

The trend: The lipstick effect may be longer lasting than it seemed just a few weeks ago when Ulta CEO Dave Kimbell said the beauty store chain has seen a pronounced slowdown in spending.

LVMH’s and L’Oréal’s earnings, along with strong beauty IPO debuts, suggest there’s still a sizable share of consumers willing to indulge in small luxuries such as face lotion, makeup, and perfume.

The evidence: LVMH’s beauty business has been “pretty strong,” CFO Jean-Jacques Guiony said during the company’s earnings call, adding there were “no particular signs of slowing down.”

  • Beauty was one of the bright spots in LVMH’s tepid Q1: Its selective retailing unit, which includes Sephora, rose 11% year over year (YoY) on an organic basis. Its perfumes and cosmetics division grew 7% YoY.
  • L’Oréal’s sales rose 9.4% on a like-for-like basis—with North American sales up 12.4%—thanks in part to its dermatological products division (which includes La Roche-Posay and CeraVe) growing 21.9%.

Market enthusiasm: While Kimbell’s comments drove a near-instant reaction from the stock market, two new IPOs suggest there’s still plenty of interest in beauty companies.

  • Skincare company Galderma Group—which owns Cetaphil, Restylane, Sculptra, and other brands—had Switzerland’s biggest IPO in two decades last month. Galderma expects sales will maintain a compound growth rate in the low- to mid-teens through 2027.
  • Puig, the fashion and beauty company behind brands such as Jean Paul Gaultier, will make its stock market debut on May 3 at a valuation of EUR 13.9 billion ($14.8 billion)—Spain’s biggest IPO in almost a decade. Puig is entering the public markets after buying brands like Charlotte Tilbury to help it compete with rivals L'Oreal and Estée Lauder.

Zooming out: We expect the beauty industry will remain strong this year. Our forecast expects US cosmetics and beauty sales to grow 6.9% in 2024, which would significantly outpace the broader retail industry’s 2.8% growth.

The big takeaway: Kimbell set off alarm bells when he spoke at a JPMorgan conference—not during the company’s earnings call—and so he may have overstated the issue or simply highlighted a company-specific challenge.

  • Ulta faces growing competition from Sephora, which is rapidly expanding its presence in department stores like Kohl’s.
  • There is also a growing share of consumers who have shifted their spending online. No retailer has benefited more from that change than Amazon, which grew its health, beauty, and personal care sales 28.2% YoY last year.

Go further: Read our Beauty Path to Purchase report.

You've read 0 of 2 free articles this month.

Create an account for uninterrupted access to select articles.
Create a Free Account